Andrew J. Fritz

Andrew J. Fritz

Auto-generated profile, based on publicly available information

Andrew J. Fritz

Department of Biochemistry and University of Vermont Cancer Center, The University of Vermont Larner College of Medicine, Burlington, Vermont

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2019 in Genes, Chromosomes and Cancer
Verified
Journal Article
Closed access
PDF file
AFAndrew J. Fritz
Andrew J. Fritz
NSNitasha Sehgal
Nitasha Sehgal
APArtem Pliss
Artem Pliss
JXJinhui Xu
Jinhui Xu
RBRonald Berezney
Ronald Berezney

4 December 2018 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
DHDeli Hong
Deli Hong
AFAndrew J. Fritz
Andrew J. Fritz
JGJonathan A. Gordon
Jonathan A. Gordon
CTCoralee E. Tye
Coralee E. Tye
JBJoseph R. Boyd
Joseph R. Boyd
GSGary S Stein
Gary S Stein

17 March 2020 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
AFAndrew J. Fritz
Andrew J. Fritz
DHDeli Hong
Deli Hong
JBJoseph Boyd
Joseph Boyd
JKJason Kost
Jason Kost
KFKristiaan H. Finstaad
Kristiaan H. Finstaad
GSGary S Stein
Gary S Stein

15 May 2017 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
AFAndrew J. Fritz
Andrew J. Fritz
PGPrachi N. Ghule
Prachi N. Ghule
JBJoseph R. Boyd
Joseph R. Boyd
CTCoralee Tye
Coralee Tye
NPNatalie A. Page
Natalie A. Page
GSGary S. Stein
Gary S. Stein


15 March 2019 in Genes, Chromosomes and Cancer
Verified
Journal Article
Open access
PDF file
AFA.J. Fritz
A.J. Fritz
NGN.E. Gillis
N.E. Gillis
DGD.L. Gerrard
D.L. Gerrard
PRP.D. Rodriguez
P.D. Rodriguez
DHD. Hong
D. Hong
GSGary S Stein
Gary S Stein
Cells establish and sustain structural and functional integrity of the genome to support cellular identity and prevent malignant transformation. In this review, we present a strategic overview of epigenetic regulatory mechanisms including histone modifications and higher order chromatin organization (HCO) that are perturbed in breast cancer onset and progression. Implications for dysfunctions that occur in hormone regulation, cell cycle control, and mitotic bookmarking in breast cancer are considered, with an emphasis on epithelial‐to‐mesenchymal transition and cancer stem cell activities. The architectural organization of regulatory machinery is addressed within the contexts of translating cancer‐compromised genomic organization to advances in breast cancer risk assessment, diagnosis, prognosis, and identification of novel therapeutic targets with high specificity and minimal off target effects.